Development asset linked to AN2 Therapeutics in public FDA and regional records.
pharma · MAC Lung Disease · Mycobacterium Abscessus Infection · ANTX
AN2 Therapeutics
AN2 Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Menlo Park, USA HQ
2019 Founded
35 Employees
Public company Type
ANTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Menlo Park, USA
- Founded
- 2019
- Employees
- 35
- Programs
- 6
- Drugs
- 2
- Patents
- 0
AN2 Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
AN2 Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to AN2 Therapeutics in public FDA and regional records.